Literature DB >> 15113884

Activation of adenoviral gene expression by protein IX is not required for efficient virus replication.

Kathy L Sargent1, Robert A Meulenbroek, Robin J Parks.   

Abstract

The adenovirus (Ad) protein IX (pIX) is a minor component of the Ad capsid and is in part responsible for virion stability; virions lacking pIX are heat labile and lose their infectivity if the DNA content is greater than approximately 35 kb. More recently, pIX has been identified as a transcriptional activator and, in transient-transfection assays, was shown to enhance expression from the E1A, E4, and major late Ad promoters by as much as 70-fold. In this study, we examined the role of pIX's ability to activate transcription during Ad replication. In transient-transfection assays, pIX had a minimal effect on expression from the E1A promoter, increasing expression by only 1.4-fold. We used helper-dependent Ad vectors, which had all Ad protein coding sequences deleted with the exception of E1A and which had capsids that either contained or lacked pIX, to show that pIX derived from decapsidation of the infecting virion does not influence expression of E1A. Similarly, expression of pIX from the Ad genome did not alter the expression levels of E1A. Viruses that had pIX deleted showed a threefold reduction in virus yield and expression of late genes compared to those of a similar virus which encoded pIX. This phenotype could not be rescued by growing the virus in cells which constitutively express pIX. Our results indicate that, although pIX can affect transcription from a variety of viral promoters, it does not appear to play a significant role in activation of Ad promoters during normal Ad replication.

Mesh:

Substances:

Year:  2004        PMID: 15113884      PMCID: PMC400331          DOI: 10.1128/jvi.78.10.5032-5037.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.

Authors:  Manuel Rosa-Calatrava; Francine Puvion-Dutilleul; Pierre Lutz; Dominique Dreyer; Hugues de Thé; Bruno Chatton; Claude Kedinger
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

2.  Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.

Authors:  K L Sargent; P Ng; C Evelegh; F L Graham; R J Parks
Journal:  Gene Ther       Date:  2004-03       Impact factor: 5.250

3.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

Authors:  R J Parks; L Chen; M Anton; U Sankar; M A Rudnicki; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.

Authors:  R J Parks; F L Graham
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre.

Authors:  L Chen; M Anton; F L Graham
Journal:  Somat Cell Mol Genet       Date:  1996-11

6.  The product of the adenovirus intermediate gene IX is a transcriptional activator.

Authors:  P Lutz; M Rosa-Calatrava; C Kedinger
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Characterization of adenovirus protein IX.

Authors:  P Boulanger; P Lemay; G E Blair; W C Russell
Journal:  J Gen Virol       Date:  1979-09       Impact factor: 3.891

8.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

Authors:  C Chartier; E Degryse; M Gantzer; A Dieterle; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX.

Authors:  W W Colby; T Shenk
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

10.  Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes.

Authors:  G Ghosh-Choudhury; Y Haj-Ahmad; F L Graham
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  17 in total

1.  Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Authors:  Kathy L Poulin; Emily R McFall; Grace Chan; Natacha B Provost; Carin Christou; Adam C Smith; Robin J Parks
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability.

Authors:  Jort Vellinga; Diana J M van den Wollenberg; Stephanie van der Heijdt; Martijn J W E Rabelink; Rob C Hoeben
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Authors:  Hideyo Ugai; Anton V Borovjagin; Long P Le; Minghui Wang; David T Curiel
Journal:  J Mol Biol       Date:  2006-12-06       Impact factor: 5.469

4.  DNA genome size affects the stability of the adenovirus virion.

Authors:  Adam C Smith; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

5.  Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development.

Authors:  Anjan Purkayastha; Susan E Ditty; Jing Su; John McGraw; Ted L Hadfield; Clark Tibbetts; Donald Seto
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

7.  Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.

Authors:  Kathy L Poulin; Robert M Lanthier; Adam C Smith; Carin Christou; Milagros Risco Quiroz; Karen L Powell; Ryan W O'Meara; Rashmi Kothary; Ian A Lorimer; Robin J Parks
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

8.  Adenoviral producer cells.

Authors:  Imre Kovesdi; Susan J Hedley
Journal:  Viruses       Date:  2010-08-16       Impact factor: 5.818

9.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

10.  Evaluation of adenovirus capsid labeling versus transgene expression.

Authors:  Jing Li; Aiman Fatima; Svetlana Komarova; Hideyo Ugai; Priyanka Uprety; Justin C Roth; Minghui Wang; Robert A Oster; David T Curiel; Qiana L Matthews
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.